123 related articles for article (PubMed ID: 16003317)
1. Factors predicting failure to identify a sentinel lymph node in breast cancer.
Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
[TBL] [Abstract][Full Text] [Related]
2. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
3. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.
Derossis AM; Fey JV; Cody HS; Borgen PI
J Am Coll Surg; 2003 Dec; 197(6):896-901. PubMed ID: 14644276
[TBL] [Abstract][Full Text] [Related]
4. Biopsy type does not influence sentinel lymph node status.
Chagpar AB; Scoggins CR; Sahoo S; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
Am J Surg; 2005 Oct; 190(4):551-6. PubMed ID: 16164918
[TBL] [Abstract][Full Text] [Related]
5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
6. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
Hieken TJ; Velasco JM
Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Tuttle TM
Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
9. [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].
Houvenaeghel G; Martino M; Jacquemier J; Moutardier V; Tallet A; Viens P; Puig B; Bardou VJ
Bull Cancer; 2003 May; 90(5):467-73. PubMed ID: 12850770
[TBL] [Abstract][Full Text] [Related]
10. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing sentinel lymph node identification failure in breast cancer surgery.
Straalman K; Kristoffersen US; Galatius H; Lanng C
Breast; 2008 Apr; 17(2):167-71. PubMed ID: 17933536
[TBL] [Abstract][Full Text] [Related]
12. Prediction of sentinel lymph node-only disease in women with invasive breast cancer.
Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
Am J Surg; 2006 Dec; 192(6):882-7. PubMed ID: 17161113
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
16. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
18. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
19. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution.
Viale G; Zurrida S; Maiorano E; Mazzarol G; Pruneri G; Paganelli G; Maisonneuve P; Veronesi U
Cancer; 2005 Feb; 103(3):492-500. PubMed ID: 15612028
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]